Symptoms include persistent sore throat, lumps in the neck, difficulty swallowing, and changes in voice or unexplained weight loss.
Join our head and neck cancer biorepository clinical trials in Oklahoma City, OK as your participation can help improve treatment and find better health outcomes for many.
Head and neck cancer, which affects your oral cavity, throat, and larynx, remains a main health concern for both men and women globally. Multiple treatment options are available yet there is a void for a better and effective therapeutic option to enhance the quality of life for those affected by this condition.
Hightower is currently conducting head and neck cancer biorepository clinical trials in Oklahoma City, OK for participants with HNSCC. The participants will undergo tissue and blood tests to analyze molecular biomarkers during their regular treatment.
Taking part in the clinical trial is free and completely up to you.
To join, just fill out the form, and a member of our research team will contact you to see if you’re eligible for the study.
Study Name | Protocol Number | Sponsor |
---|---|---|
Head and Neck | Tempus |
Hightower is currently conducting biorepository clinical trials for individuals with head and neck squamous cell carcinoma (HNSCC). Participants will have tissue and blood samples collected to analyze molecular biomarkers as part of their standard treatment.
This trial is a prospective, longitudinal, non-interventional, multicenter study of individuals with HNSCC. The head and neck cancer biorepository clinical trials in Oklahoma City, OK aim to conduct molecular biomarkers profiling during participants’ standard of care treatment.
The study aims to monitor biomarkers in a targeted patient population with metastatic or unresectable, recurrent HNSCC and aims at first-line immunotherapy or combination therapy.
*All study procedures, including the study-related treatment and the investigational drug, are provided at no cost, and no insurance is needed to join.
*The study doctor will guide you through each step of the clinical trial, addressing any questions you may have about the treatment before you decide to participate.
Once you agree to enroll in our study, you will be asked to sign an Informed Consent Form, which provides detailed information about the study. Our research team will guide you through the study process and explain your role in the trials. We encourage you to ask any questions you may have before deciding whether to participate or withdraw from the trial.
After signing the consent form and addressing all your questions, there will be timely blood sample collection and regular monitoring.
This study involves up to 500 participants with head and neck cancer (HNSCC) located in areas such as the throat, voice box, mouth, or oropharynx. These participants will receive either their first round of immunotherapy or a combination of therapies.
*Study-related care is provided free of charge, and experienced physicians will conduct thorough physical exams and assessments throughout the process.
18 years and older
All
HNSCC
Recruiting
HNSCC is a type of cancer that develops in the mucosal surfaces of the head and neck, such as the mouth, throat, and larynx. The main culprits behind them are risk factors like tobacco use, alcohol consumption, or HPV infection.
Symptoms include persistent sore throat, lumps in the neck, difficulty swallowing, and changes in voice or unexplained weight loss.
It is diagnosed through physical exams, imaging tests (like CT or MRI scans), and biopsies to check for cancerous cells.
Treatment options include surgery, radiation therapy, chemotherapy, and targeted therapies depending on the cancer stage and location.
Participants receive investigational treatments, and their response is monitored to evaluate safety and effectiveness in improving health outcomes.
Participation offers access to new treatments and contributes to research that may improve future care for others with head and neck cancer.